Huadong Medicine financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥2.88B ¥3.48B ¥3.97B ¥4.85B ¥6.02B ¥7.82B ¥8.97B ¥11.13B ¥14.58B ¥16.72B ¥18.95B ¥21.73B ¥25.38B ¥27.83B ¥30.66B ¥35.45B ¥33.68B ¥34.56B ¥37.71B ¥40.62B ¥0.00M
GM % Gross Margin %
17.00% 17.96% 19.98% 21.41% 19.36% 19.98% 18.76% 19.63% 19.54% 20.18% 21.97% 23.98% 24.27% 26.12% 28.98% 32.06% 33.04% 30.65% 31.89% 32.38% 0.00%
OM Operating Margin
3.95% 4.99% 5.39% 7.37% 5.98% 7.44% 5.74% 6.35% 6.25% 6.21% 6.88% 7.27% 7.58% 8.22% 9.39% 8.99% 8.98% 8.12% 8.36% 8.84% 0.00%
EPS Earnings Per Share
¥0.05 ¥0.11 ¥0.11 ¥0.23 ¥0.19 ¥0.24 ¥0.30 ¥0.35 ¥0.47 ¥0.68 ¥0.99 ¥1.28 ¥1.47 ¥1.39 ¥1.25 ¥1.38 ¥1.56 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.04 ¥0.00 ¥0.00 ¥0.09 ¥0.09 ¥0.09 ¥0.17 ¥0.19 ¥0.26 ¥0.35 ¥0.38 ¥0.40 ¥0.28 ¥0.28 ¥0.23 ¥0.29 ¥0.29 ¥0.58 ¥0.00
PR % Payout Ratio %
0 0 80.00% 0 0.00% 39.13% 47.37% 37.50% 56.67% 54.29% 55.32% 51.47% 0 40.40% 21.88% 19.05% 16.55% 23.20% 21.01% 37.18% 0
Sha. Shares
1954.28m 1954.28m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1749.81m 1749.81m 1749.81m 1749.81m 1749.81m 1749.81m 1749.81m 0m 1750.14m
OCF Operating Cash Flow
¥12.51M ¥0.00M ¥68.38M ¥265.79M ¥344.69M ¥567.94M ¥-27.99M ¥24.57M ¥642.73M ¥476.98M ¥740.85M ¥658.54M ¥1.35B ¥1.66B ¥2.04B ¥2.00B ¥3.41B ¥3.17B ¥2.38B ¥3.93B ¥0.00M
FCF Free Cash Flow
¥-54.09M ¥0.00M ¥-15.15M ¥233.52M ¥256.45M ¥438.68M ¥-198.85M ¥-199.64M ¥385.76M ¥141.14M ¥416.74M ¥275.53M ¥880.81M ¥1.18B ¥1.17B ¥648.26M ¥1.94B ¥2.35B ¥1.20B ¥1.89B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥0.00 ¥-0.01 ¥0.15 ¥0.16 ¥0.28 ¥-0.13 ¥-0.13 ¥0.25 ¥0.09 ¥0.27 ¥0.18 ¥0.51 ¥0.68 ¥0.66 ¥0.37 ¥1.11 ¥1.34 ¥0.68 ¥1.33 ¥0.00